Log In
Print
BCIQ
Print
Print this Print this
 

LCZ696

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionDual inhibitor of angiotensin II type 2 (AT2) receptor (ATGR2) and neutral endopeptidase (neprilysin; MME; NEP; CD10)
Molecular Target Angiotensin II type 2 (AT2) receptor (ATGR2) ; Neutral endopeptidase (neprilysin) (MME) (NEP) (CD10)
Mechanism of ActionNeutral endopeptidase inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today